Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

RET in Lung Cancer: The Next Big Target?
gracevideo
Wed, 07/08/2015 - 06:00
Please Note: While this is Still Excellent Background Info, New Treatments and Procedures Have Emerged Since this Original Post
Author
GRACE Videos and Articles

A trial studying Cometriq (cabozantinib) for RET rearrangements showed a promising response rate, which led the doctors to discuss if they think RET is going to be the next actionable target in lung cancer.

 

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Tags
cabozantinib
Cometriq
Dana Farber Cancer Institute
erlotinib
Howard Jack West
Howard West
Institut Gustave Roussy
Jack West
Jean-Charles Soria
Leena Gandhi
non-small cell lung cancer
NSCLC
RET
Swedish Cancer Institute
tarceva
Targeted Therapies

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

Mandarin LCVL
2022 Program: Mandarin LCVL
Video
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit: https://www.youtube.com/playlist?list=PLWsyUmdjLXhGnSxobmz4CBP3pxAj7nDa…;  
Tell your story! Apply now for the Clinical Trials Experiences through Storytelling Program
Apply Now! Be a Part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program
Article
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now!     GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview  
Blood Cancer OncTalk
Blood Cancer OncTalk 2022
Video
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.

Forum Discussions

Apply Now! Be a Part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program
TAGRISSO vs TAGRIX vs GEFTINIB

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

another question about Tagrisso not working and alternatives

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Who Should Get Biomarker Testing for NSCLC?
Information everyone should have :)
GRACE Video - Staging Lung Cancer
Ischial body

Hi Kimberly, Welcome to Grace.  I'm sorry you are here and glad you've found us. 


 


It sounds like a biopsy would be the next step.  I can't speak to what...

Recent Comments

JOIN THE CONVERSATION
Neck and shoulder pain with hard bump on collarbone
Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
Neck and shoulder pain with hard bump on collarbone
Concerned
By Tndiuka10 on Fri, 05/12/2023 - 21:13
TAGRISSO vs TAGRIX vs GEFTINIB
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
another question about Tagrisso not working and alternatives
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29